CBPO has been doing great! Since Dec. uplisting, it finally appeared in IBD rating. At the beginning, it was incomplete and hover around 60-70. This morning I checked again, it is already #1 in its group which includes power house like Amgen. It should be cracking IBD#100 soon in this rate.
Its TTM EPS (non-gaap) is 1.01 and apply only 30% growth for 2010. It will be only 1.31. Assigning PE=15 as it is much safer play now in big board and potential increase from indexes and instituional buyers. The target is 19.7, which should leave about 50% PPS growth in 2010. So holding for LTCG for 2010 seems to be safe bet.
News 
Market Data 
Discover 
AI
